Publications
17.01.2019
Early payer scientific advice procedures

The objective of this research was to understand the processes and outputs from different European p...

Read more
Articles
12.12.2018
Medicare drug pricing

Medicare would use a new International Pricing Index (IPI) model that considers international refere...

Read more
News
19.11.2018
Pfizer hike list price of 41 medicines

Pfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire ...

Read more
Publications
14.11.2018
ISPOR 2018 Companies market access training

Setting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...

Read more
Articles
24.10.2018
Patient access to high-cost orphan drugs

Orphan drugs have important societal value as they improve patient quality of life and address unmet...

Read more
News
09.10.2018
CSL Behring lung drug cost NHS £8m

NHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...

Read more
Case Studies
21.09.2018
Payer value proposition development

Understanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...

Read more
Publications
06.09.2018
NICE appraisals process for oncology indications

Since 29th July 2016 the NICE appraisal process for oncology indications in England has been modifie...

Read more
Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Articles
17.08.2018
Biosimilars Price Controls

The government has launched a consultation that outlines the proposed changes to its price controls ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.